EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases

Adriana Jiménez, Enrique Estudillo iD, Mara A Guzmán-Ruiz, Nieves Herrera-Mundo iD, Georgina Victoria-Acosta iD, Enoc Mariano Cortés-Malagón iD, Adolfo López-Ornelas

Pharmaceutics · 20.02.2025 · 17 (3) · 281

DOI: 10.3390/pharmaceutics17030281 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.02.2025. Verfasst von Adriana Jiménez und 6 weiteren Autor:innen. Beteiligte Einrichtung: División de Investigación, Hospital Juárez de México, Ciudad de México 07760, Mexico. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 285 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Juárez de México.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blood–brain barrier (BBB) is a critical structure that maintains brain homeostasis by selectively regulating nutrient influx and waste efflux. Not surprisingly, it is often compromised in neurodegenerative diseases. In addition to its involvement in these pathologies, the BBB also represents a significant challenge for drug delivery into the central nervous system. Nanoparticles (NPs) have been widely explored as drug carriers capable of overcoming this barrier and effectively transporting therapies to the brain. However, their potential to directly address and ameliorate BBB dysfunction has received limited attention. In this review, we examine how NPs enhance drug delivery across the BBB to treat neurodegenerative diseases and explore emerging strategies to restore the integrity of this vital structure.

Schlagwörter

Stichwörter der Autor:innen

blood–brain barriernanoparticlesnanotechnologyneurodegenerative diseasesstem cells

Autor:innen und Institutionen

  • División de Investigación, Hospital Juárez de México, Ciudad de México 07760, Mexico.
  • Laboratorio de Reprogramación Celular, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Ciudad de México 14269, Mexico.
  • Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
  • Departamento de Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
  • Hospital Nacional Homeopático, Hospitales Federales de Referencia, Ciudad de México 06800, Mexico.

ORCID-Profile: Enrique Estudillo, Nieves Herrera-Mundo, Georgina Victoria-Acosta, Enoc Mariano Cortés-Malagón

Förderung

  • Hospital Juárez de México

Zitieren

APA

Jiménez, A., Estudillo, E., Guzmán-Ruiz, M. A., Herrera-Mundo, N., Victoria-Acosta, G., Cortés-Malagón, E. M., & López-Ornelas, A. (2025). Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases. Pharmaceutics, 17(3), 281. https://doi.org/10.3390/pharmaceutics17030281

Vancouver

Jiménez A, Estudillo E, Guzmán-Ruiz MA, Herrera-Mundo N, Victoria-Acosta G, Cortés-Malagón EM, et al. Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases. Pharmaceutics. 2025;17(3):281. doi:10.3390/pharmaceutics17030281

BibTeX
@article{Jimnez2025,
  author = {Jiménez, Adriana and Estudillo, Enrique and Guzmán-Ruiz, Mara A and Herrera-Mundo, Nieves and Victoria-Acosta, Georgina and Cortés-Malagón, Enoc Mariano and López-Ornelas, Adolfo},
  title = {Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {281},
  doi = {10.3390/pharmaceutics17030281}
}
Kostenlos starten →